Search results
USPTO Considering Changes to Enforceability of Patents Subject to A Terminal Disclaimer
The National Law Review· 13 hours agoOn 10 May 2024, the United States Patent and Trademark Office (USPTO) published a Notice of Proposed...
Northstar Issued Second Patent by United States Patent & Trademark Office and Amends Stock Options
FOX 59 Indianapolis· 15 hours agoNorthstar Clean Technologies Inc. (TSXV: ROOF) (OTCQB: ROOOF) ("Northstar" or the "Company") is...
Strategies for Successful Patent Owner Reexamination Requests | JD Supra
JD Supra· 1 day agoPatent owner requested reexaminations are not an admission of claim unpatentability. Patent owners can and should control the reexamination request narrative ...
United States Patent & Trademark Office Proposes Rule that Would LimitPatent Owner’s Enforcement...
JD Supra· 3 days agoOn May 10, 2024, the United States Patent & Trademark Office (USPTO) published a proposed rule under which terminal disclaimers filed to obviate an obviousness-type double ...
USPTO's Notice of Proposed Rulemaking on Terminal Disclaimer Practice | JD Supra
JD Supra· 2 days agoOn May 10, 2024, the United States Patent and Trademark Office (USPTO) published a notice of proposed rulemaking (NPRM) that proposes a rule regarding...
Navigating AI Integration: USPTO's New Guidance for Patent and Trademark Practices
The National Law Review· 7 days agoThe United States Patent and Trademark Office (USPTO) has issued a pivotal guidance document,...
Valley medical startup ReSuture obtains patent for surgical training technology
The Business Journals· 15 hours agoReSuture, a Surprise-based medtech startup, has obtained a patent for surgical training technology...
Columbus bars and restaurants keep the classic old fashioned alive with modern riffs
The Columbus Dispatch via Yahoo News· 2 hours agoAt Cobra, the old fashioned is made with two kinds of bitters, the patent medicine-turned-cocktail...
CardioPharma Announces Issuance of Global Patent to Mitigate the World's Top Killer
The Advocate & Democrat· 2 days agoCardioPharma Inc. (the "Company"), a specialty pharmaceutical company focused on drug development for cardiovascular diseases, announced that on August 29, 2023, the United States Patent ...
USPTO’s Guidance on AI-Based Tools | JD Supra
JD Supra· 2 days agoEarlier this month, the United States Patent and Trademark Office (USPTO) and the United States Department of Commerce issued guidance on the use of artificial intelligence ...
